Therefore, our study provides a novel understanding of the role of vimentin and associated molecular mechanisms with LASP1 in HBX-mediated hepatocarcinogenesis and may provide new therapeutic targets for HBV-related HCC treatment. This evidence concerns the gene LASP1 and hepatocellular carcinoma.